Search

Boehringer Ingelheim becomes member of IPC

Boehringer Ingelheim becomes member of IPC Boehringer Ingelheim is proud to join the International Poultry Council thus reaffirming its strong long-term commitment to shaping the future of poultry health. The International Poultry Council represents a uni

Boehringer Ingelheim and GST prepared bring innovation to equine market

Boehringer Ingelheim and Global Stem Cell Technology are prepared to bring groundbreaking innovation to equine market

Inauguration of new global center for veterinary vaccine R&D

Inauguration of a new global hi-tech centre for biological research and development in Lyon.

2018 Animal Welfare Medals

2018 Animal Welfare Medals: Boehringer Ingelheim recognizes outstanding research in cattle, equine, swine, as well as small animals and pet categories

Partnership to further develop pet market in China

Boehringer Ingelheim invests in partnership to further develop the pet market in China, acquires a stake in New Ruipeng Group

LastMile – improving through digital

LastMile initiative is an integrated, solutions-driven program seeking to make animal medical resources available in hard-to-reach areas in Africa.

Classical Swine Fever live vaccine approved in China

Boehringer Ingelheim’s China-developed Classical Swine Fever live vaccine approved

Veterinary oncology experts meet in Germany

Veterinary oncology experts meet prior to the European Society of Veterinary Oncology Congress in Hofheim, Germany

biopharmaceuticals-in-china

Boehringer Ingelheim manufactures the first biopharmaceutical approved in China under new MAH contract manufacturing regulatory system.

Translating Human Pharma Science into Animal Health Innovation

Megan Grether shares her perspectives on the importance of translating human pharma science to accelerate innovation in animal health

Corporate volunteering boosts social impact - A win for all.

Boehringer Ingelheim corporate volunteers help people with disabilities. Volunteering has social impact and benefits employees, employers, and communities.

Three challenges shape future antiparasitic treatment

The three key challenges that will shape the future of antiparasitic treatment

Celebrating 20 years of Metacam for cattle

Celebrating 20 years of Metacam (Meloxicam) for cattle

NexGard COMBO for cats EMA marketing authorization

Boehringer Ingelheim received marketing authorization from the EMA (European Medicine Agency) for its NexGard® COMBO topical solution for cats.

The first liquid solution for hypertension in cats

Boehringer Ingelheim launches Semintra® 10 mg/ml Oral Solution in selected European countries for the treatment of feline hypertension.

Purevax range now available in 0.5 ml presentation

Boehringer Ingelheim announces reduced volume 0.5 ml Purevax vaccines for cats, more convenient vaccination experience combined with same efficacy

New exchange platform with Harbin Research Institute

Boehringer Ingelheim and Harbin Veterinary Research Institute set up ‘industry-academia-research’ exchange platform

cystic fibrosis phase II trial

The first patient has been enrolled in a phase II trial to evaluate an innovative treatment for cystic fibrosis, inhaled via the Respimat® inhaler

New African Swine Fever Manual published

Boehringer Ingelheim joined forces with the leading veterinarians to fight African swine fever. The new African Swine Fever Knowledge Handbook published.

Positivity... just a paw away

Data released by Boehringer Ingelheim shows the 96% of dog owners and 91% of cat owners claim their pet has a positive impact on their daily lives.

Launch of BVDzero scholarship for veterinary students

Launch of BVDzero scholarship for veterinary students globally

Aservo EquiHaler wins Red Dot 2020 for design quality

Aservo EquiHaler wins a prestigious Red Dot Award 2020 for outstanding design quality

Behavioral science to improve cattle well-being

Boehringer Ingelheim kicks off a project based on behavioral science to improve cattle well-being

commitments to sustainable development

On One Health Day, Boehringer Ingelheim shares an update on its strategic approach to sustainability for employees, partners and wider communities

BI increases commitments to sustainable development

At the World Health Summit 2021, Boehringer Ingelheim announces updates to its strategic approach to sustainable development

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers